Mechanism of Action and Selectivity of Amlodipine

Pharmacologic Mechanism

• Amlodipine is a long‑acting dihydropyridine calcium‑channel blocker that selectively inhibits voltage‑gated L‑type calcium channels on vascular smooth‑muscle cells, producing potent peripheral and coronary vasodilation while having minimal impact on cardiac contractility, conduction, or heart rate. 1

• Unlike non‑dihydropyridine calcium‑channel blockers such as diltiazem and verapamil, amlodipine shows high vascular selectivity and does not cause negative inotropic, chronotropic, or dromotropic effects. 1

Clinical Safety Considerations

• Immediate‑release nifedipine must not be substituted for amlodipine because it induces rapid vasodilation, reflex tachycardia, and is contraindicated in acute coronary syndromes. 2, 3

• Non‑dihydropyridine calcium‑channel blockers (diltiazem, verapamil) should not replace amlodipine in patients with heart failure, as they have negative inotropic effects that amlodipine lacks. 2, 3

Amlodipine Onset of Action and Clinical Implications

Clinical Evidence and Guidelines

• The American Heart Association and American College of Cardiology guidelines state that immediate-release nifedipine should not be administered in acute coronary syndromes due to harm from rapid blood pressure reduction, highlighting the importance of gradual onset agents like amlodipine 4
• Amlodipine is inappropriate for acute blood pressure management, such as in hypertensive emergencies or acute coronary syndromes requiring rapid control, according to the American Heart Association 4